Globus Medical, Inc.
General ticker "GMED" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $9.4B (TTM average)
Globus Medical, Inc. follows the US Stock Market performance with the rate: 25.8%.
Estimated limits based on current volatility of 1.9%: low 91.19$, high 94.78$
Factors to consider:
- Total employees count: 5300 as of 2024
- US accounted for 79.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Key management loss, Product safety and efficacy risks, Acquisition/divestiture risks, Cybersecurity threats, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [68.73$, 98.76$]
- 2025-12-31 to 2026-12-31 estimated range: [72.04$, 103.77$]
Financial Metrics affecting the GMED estimates:
- Negative: with PPE of 26.4 at the end of fiscal year the price was high
- Positive: -5.02 < Operating profit margin, % of 6.59
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 1.92
- Positive: -4.41 < Investing cash flow per share per price, % of -1.56
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 79.54 > 64.17
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Positive: 0.04 < Operating cash flow per share per price, % of 4.63
- Positive: Inventory ratio change, % of -14.42 <= -0.76
Short-term GMED quotes
Long-term GMED plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,022.84MM | $1,568.48MM | $2,519.36MM |
| Operating Expenses | $794.89MM | $1,435.33MM | $2,353.36MM |
| Operating Income | $227.95MM | $133.14MM | $165.99MM |
| Non-Operating Income | $15.07MM | $32.25MM | $-45.27MM |
| R&D Expense | $73.02MM | $124.01MM | $163.75MM |
| Income(Loss) | $243.02MM | $165.39MM | $120.72MM |
| Taxes | $52.85MM | $42.52MM | $17.74MM |
| Profit(Loss)* | $190.17MM | $122.87MM | $102.98MM |
| Stockholders Equity | $1,846.37MM | $3,997.96MM | $4,177.33MM |
| Inventory | $298.98MM | $848.13MM | $659.23MM |
| Assets | $2,076.13MM | $5,086.08MM | $5,251.75MM |
| Operating Cash Flow | $178.47MM | $243.50MM | $520.64MM |
| Capital expenditure | $74.05MM | $78.27MM | $115.43MM |
| Investing Cash Flow | $-110.36MM | $302.97MM | $-176.05MM |
| Financing Cash Flow | $-109.96MM | $-231.82MM | $-27.70MM |
| Earnings Per Share** | $1.89 | $1.09 | $0.76 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.